Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06500286Phase 1Not yet recruiting
Phase 1, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Efficacy of dorsal penile block at 1 year. Planned start Aug 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06500286.